Please login to the form below

Not currently logged in
Email:
Password:

personalised medicines

This page shows the latest personalised medicines news and features for those working in and with pharma, biotech and healthcare.

The shifting healthcare landscape

The shifting healthcare landscape

With more personalised medicines targeting specific patient groups, payers cannot apply the old funding approach but need to find new ways to reward innovation. ... Many of these future opportunities rely on companies stepping out of their corner as a

Latest news

  • The state of trust The state of trust

    There is, however, a trust relationship between government and pharma regarding the production of medicines, but the big problem we have is that pharma doesn’t talk directly to patients. ... Healthy distrust. With the introduction of personalised

  • Revolutionising how healthcare is delivered Revolutionising how healthcare is delivered

    Imagine if a shipment holding medicine that was personalised for the DNA of a cancer patient was spoiled or stolen. ... The complete visibility of healthcare shipments is needed as medicines become more personalised and more potent.

  • NICE: We're the institute of 'yes' NICE: We're the institute of 'yes'

    However, he questioned the industry's current approach to setting out the value offered by new medicines. ... Personalised medicine challenges. The QuintilesIMS meeting also discussed the scale of the health technology assessment challenge presented by

  • EMA starts firming up its stance on personalised medicines EMA starts firming up its stance on personalised medicines

    EMA starts firming up its stance on personalised medicines. But draft guidelines won't be ready much before 2019. ... New draft European guidelines on personalised medicines and companion diagnostics are expected to be released by December 2018.

  • Novartis and Bayer among backers for European big data project Novartis and Bayer among backers for European big data project

    and personalised medicines through advanced analytics. ... Data science techniques to develop new definitions of disease, identify new phenotypes, and construct personalised predictive models.

More from news
Approximately 14 fully matching, plus 57 partially matching documents found.

Latest Intelligence

  • Patently unclear? Patently unclear?

    Another example of such obstacles is the question of whether you can get patent protection for methods of diagnosing disease and for personalised medicine. ... It appears that the situation is still evolving and that for the time being getting patent

  • Real-world evidence Real-world evidence

    work to answer important clinical questions (which may have not been possible otherwise), and it can support the development of evidence-based personalised medicines through the linking of electronic medical records

  • Stronger together Stronger together

    Most recently the European Medicines Agency raised its expectations of pharmaceutical companies, calling for closer integration of patients' views when it issued new guidance last month on the use of ... As new medical technologies like stem cells and

  • It's behind you! It's behind you!

    The advent of smart contact lenses, wearable technologies and personalised medicines offer a tantalising glimpse into the future and how we may understand and assess the patient.

  • Harnessing the power of genetics Harnessing the power of genetics

    Harnessing the power of genetics. In oncology, and other therapy areas, personalised medicines offer new hope against chronic illnesses. ... This in turn is holding back the full promise of personalised medicines from being realised given their reliance

More from intelligence
Approximately 4 fully matching, plus 11 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Medicines personalised for Tom, Dick and Harry

    Medicines personalised for Tom, Dick and Harry. Dorothy may have finally got home to Kansas, but are we doomed to keep following the Yellow Brick Road? ... And so enters the concept of personalised medicine with the aim of providing treatments to

  • Being Human - The healthcare angle

    The industry is busily developing innovative, often personalised medicines, but we’ re under unprecedented scrutiny.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics